* STENTYS *
2006 - IDF
Paris
www.stentys.com Design, Devices
Key words: Stent, Heart-Attack, Revascularisation,
Mission: to develop a new generation of self-expanding stents or self-apposing stents, specialized in the treatment of heart attacks (or Acute Myocardial Infarction)
Clients: Device Industry, Hospitals
info@stentys.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Start-up |
Managing Dir.-CEO: Issenmann (Gonzague) [co-founder, born 1972, MBA, ex-CordisJ&J]
Sc.Dir.-CSO:
Fin.Dir.-CFO: Piot (Stanislas) [Ms. finance and economics, ex-Ipsogen, Banque Worms, Crédit Lyonnais, Oddo, Natixis]
BusDev:
Financers (Hist.): Sofinnova Partners, Scottish Equity Partners, Crédit Agricole Private Equity, Public (registered capital 2009 = 0.16 M€) | Turnover (M€) : n.a.
Total funding (M€) : 38.9
Last funding (M€) : 22.7
Focus : Cardiovasc
Position : Trade
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2011 .03 | Launch of drug-eluting stent in 4 additional EU countries, Scandinavia, Spain, Switzerland and Poland | MKTG | [4 years] |
| 2011 .02 | Launch of drug-eluting stent in Germany, with increased reimbursement (and also the Netherlands) | MKTG | [4 years] |
| 2010 .10 | Listing on Euronext : 22.7 M€ (IPO) | PBO | [4 years] |
| 2009 .12 | Clinical trial of Apposition vs. standard stent (beginning) | CLIN | [3 years] |
| 2009 .09 | Clinical trial of Apposition, first self-expanding stent (results) | CLIN | [3 years] |
| 2006 .07 | Company founded by Jacques Séguin [M.D. cardiology, Ph.D., ex-founder CoreValve] and Gonzague Issenmann [company also based in Princeton, New Jersey, USA] | ORGF | [0 year] | Actualisation / Updating: 9-May-2011 |
|
